EUVIMEDEUVIMED entdecken
Crossref

Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case–control study

E Şenel, M Salmanoğlu, E Solmazgül, B Berçik İnal

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.4396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von E Şenel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Merzifon Military Hospital, Amasya, Turkey. Hauptthemen laut MEDLINE: Hyperlipidemias, Glucose Intolerance, Skin Neoplasms, Hypertension. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Pfizer Inc., Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acrochordons are common and benign skin tumours. A few studies with contradictory results have been reported regarding the abnormalities of carbohydrate and/or lipid metabolisms in patients with acrochordons.

Objectives

We aimed to determine if the presence of acrochordons could be a marker of diabetes, hyperlipidemia, liver enzyme abnormalities and hypertension by comparing with a control group.

Methods

A total of 110 patients having two or more acrochordons and age‐ and gender‐matched 110 controls were included in the study. Localization, size and the total number of acrochordons were recorded in the patient group. Fasting plasma glucose (FPG), serum lipids and liver enzyme levels were tested in patient and controls. All participants underwent a standard 2‐h oral glucose tolerance test with 75 g glucose. Diabetes mellitus and impaired glucose intolerance were diagnosed according to the American Diabetes Association criteria. Arterial blood pressures were measured in two groups.

Results

A total of 56 patients and 10 controls were diagnosed with overt DM. Thirteen per cent of the patients and 9% of controls had an impaired glucose tolerance test. The difference was statistically significant for the diagnosis of DM and not significant for the impaired glucose tolerance. The mean levels of FPG, total cholesterol, LDL cholesterol, triglyceride, aspartate aminotransferase, alanine aminotransferase, gamma‐glutamyltransferase and alkaline phosphatase were significantly higher in patients than those in controls. Furthermore, serum levels of HDL were less in patients. Patients with acrochordons had higher systolic and diastolic blood pressures than controls.

Conclusions

The results of our study suggest that acrochordons may represent a cutaneous sign for impaired carbohydrate or lipid metabolism, liver enzyme abnormalities and hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperlipidemiasGlucose IntoleranceSkin NeoplasmsHypertensionHumansCase-Control StudiesCarbohydrate MetabolismCarbohydratesLiver

Substanzen

Carbohydrates

Autor:innen und Institutionen

  • Department of Dermatology, Merzifon Military Hospital, Amasya, Turkey.
  • Department of Internal Medicine, Merzifon Military Hospital, Amasya, Turkey.
  • Department of Biochemistry, Ministry of Health İstanbul Education and Research Hospital, İstanbul, Turkey.

Förderung

  • Pfizer Inc.
  • Pfizer

Zitieren

APA

Şenel, E., Salmanoğlu, M., Solmazgül, E., & İnal, B. B. (2023). Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case–control study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.4396

Vancouver

Şenel E, Salmanoğlu M, Solmazgül E, İnal BB. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case–control study. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.4396

BibTeX
@article{enel2023,
  author = {Şenel, E and Salmanoğlu, M and Solmazgül, E and İnal, B Berçik},
  title = {Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: A case–control study},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.4396}
}
Kostenlos starten →